SyntekaBio, Inc. (KOSDAQ:226330)
South Korea
· Delayed Price · Currency is KRW
3,220.00
-20.00 (-0.62%)
At close: Apr 28, 2026
SyntekaBio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 78,476 | 59,432 | 80,107 | 216,882 | 115,982 | 241,650 | |
| Market Cap Growth | -24.25% | -25.81% | -63.06% | 87.00% | -52.00% | -21.37% | |
| Enterprise Value | 69,257 | 70,195 | 71,044 | 189,591 | 86,513 | - | |
| Last Close Price | 3235.00 | 3895.00 | 4388.79 | 11904.07 | 7172.54 | 14963.68 | |
| PS Ratio | 22.88 | 17.33 | 662.66 | 1757.47 | 475.35 | 763.13 | |
| PB Ratio | 2.47 | 1.87 | 3.21 | 6.95 | 3.69 | 8.75 | |
| P/TBV Ratio | 2.50 | 1.89 | 3.27 | 7.05 | 3.76 | 8.89 | |
| EV/Sales Ratio | 20.20 | 20.47 | 587.69 | 1536.32 | 354.57 | - | |
| Debt / Equity Ratio | 0.22 | 0.22 | 0.29 | 0.07 | 0.35 | 0.32 | |
| Net Debt / Equity Ratio | -0.29 | -0.29 | -0.19 | -0.56 | -0.77 | -1.59 | |
| Net Debt / EBITDA Ratio | 1.06 | 1.06 | 0.40 | 1.67 | 2.35 | 5.67 | |
| Net Debt / FCF Ratio | 0.87 | 0.87 | 0.29 | 1.01 | 1.43 | 3.25 | |
| Asset Turnover | 0.08 | 0.08 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Quick Ratio | 1.41 | 1.41 | 0.74 | 1.02 | 1.59 | 28.00 | |
| Current Ratio | 1.42 | 1.42 | 0.77 | 1.13 | 1.69 | 30.82 | |
| Return on Equity (ROE) | -61.27% | -61.27% | -25.68% | -36.36% | -15.25% | -42.80% | |
| Return on Assets (ROA) | -14.91% | -14.91% | -18.46% | -14.13% | -11.93% | -9.87% | |
| Return on Capital Employed (ROCE) | -31.40% | -31.40% | -52.10% | -36.60% | -35.30% | -13.50% | |
| Earnings Yield | -22.14% | -29.24% | -9.00% | -5.25% | -3.89% | -6.13% | |
| FCF Yield | -13.58% | -17.94% | -20.24% | -8.04% | -14.57% | -5.59% | |
| Buyback Yield / Dilution | -2.20% | -2.20% | -6.52% | -5.94% | -0.37% | -1.65% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.